News Release

 

Back
 

AmeriSource Completes Secondary Share Issue

02/10/99

    Business Editors

    MALVERN, Pa.--(BUSINESS WIRE)--Feb. 10, 1999--AmeriSource Health Corp. (NYSE:AAS), one of the nation's leading pharmaceutical distributors, announced today that it has successfully completed a secondary public offering of six million shares of common stock priced at $76.50 per share.
    All of the shares sold in the offering were held by affiliates of Citicorp Venture Capital, Ltd. (CVC).
    R. David Yost, President and CEO of AmeriSource Health said, "We embarked on a rigorous national roadshow to reconfirm our position as an industry leader and to convey the future outlook of AmeriSource. This ambitious exercise combined with the proposed two-for-one stock split, will yield a broader shareholder base and improve the liquidity of the AmeriSource common stock. It has also provided another opportunity to reinforce our commitment to maximizing share value."
    CVC will retain approximately 720,000 shares of AmeriSource common stock. The offering was led by Salomon Smith Barney and Donaldson Lufkin & Jenrette and co-managed by J.P. Morgan & Co., First Union Capital Markets, McDonald Investments, and Piper Jaffray, Inc.
    AmeriSource Health Corp. is a Fortune 200 company with revenues of $8.7 billion for fiscal year end 1998. The Company is one of the nation's leading pharmaceutical distributors and serves the healthcare industry from a nationwide network of 23 strategically located distribution centers. News and additional information about AmeriSource are available at www.amerisource.com

    Certain information contained in this press release includes forward-looking statements (as defined in Section 27A of the Securities Act and Section 21E of the Exchange Act) that reflect the Company's current views with respect to future events and financial performance.
    Certain factors such as competitive pressures, success of restructuring initiatives, continued industry consolidation, changes in customer mix, changes in pharmaceutical manufacturers' pricing and distribution policy, the loss of one or more key customer or supplier relationships and other matters contained in the Company's Form 10-K for fiscal year 1998 and other public documents could cause actual results to differ materially from those in the forward-looking statements.
    The Company assumes no obligation to update the matters discussed in this press release.

     CONTACT:  AmeriSource Health Corp.
               MaryBeth Alvin, director, Investor Relations
               610/296-4480
               malvin@amerisource.com

Corporate Overview

AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel..

Learn More